Form 8-K · Current Report · Filed 2025-07-30
Hologic Reports Q3 2025 Earnings Exceeding Guidance
Hologic, Inc. reported its financial results for the third quarter of fiscal 2025, showing revenue of $1,023.8 million, which exceeded the guidance range of $1,000 to $1,010 million. GAAP diluted EPS of $0.86 increased by 4.9% year-over-year, and non-GAAP diluted EPS of $1.08 exceeded the guidance range of $1.04 to $1.07. The company's financial performance was driven by robust molecular diagnostics sales, international growth, and strategic acquisitions. Hologic also provided updated financial guidance for the fourth quarter and full fiscal year 2025, anticipating continued revenue growth and faster non-GAAP EPS growth.
- Filer
- Hologic Inc. HOLX · NASDAQ
- Filed
- Accession
- 0001140361-25-028008
- CIK
- 0000859737
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Results of Operations and Financial Condition
Financial Statements and Exhibits
Market reaction
Close before filing
$66.04
Next session
+1.2%
Since filing
+15.1%
Latest close
$76.01
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from HOLX reporting the same item, with the next session's move:
Exhibits (1)
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Never miss another HOLX filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.